|
Piramal Pharma's Sellersville unit gets Form-483 with three observations from US FDA> |
|
Piramal Pharma reports consolidated net loss of Rs 8.83 crore in the March 2026 quarter> |
|
Piramal Pharma Ltd up for five straight sessions> |
|
Piramal Pharma Ltd soars 6.62%, Gains for third straight session> |
|
Volumes soar at Clean Science & Technology Ltd counter> |
|
Piramal Pharma announces board meeting date> |
|
Piramal Pharma Ltd spurts 2.13%, rises for third straight session> |
|
Piramal Pharma receives EIR for manufacturing facility located at Lexington> |
|
Piramal Pharma gets EIR for Lexington facility from US FDA> |
|
Indices trade lower amid weak global cues; oil & gas shares drop> |